Mangoceuticals /
Nuclea
Mangoceuticals agrees to buy Nuclea




Source for the buyer and target: Mangoceuticals, Inc.
For the buyer and target.
“On July 30, 2026, Mangoceuticals announced that it had entered into a definitive business combination agreement (the “Business Combination Agreement”) with Nuclea.”
Published 6 Aug 2026
Open the sourceWhat happened
Mangoceuticals agreed to acquire Nuclea, according to a filing dated Aug. 6, 2026. [01]
The source
Everything on this page comes from the source below, quoted word for word.
Mangoceuticals agrees to buy Nuclea
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
Announced
“Mangoceuticals agrees to buy Nuclea Mangoceuticals agreed to acquire Nuclea, according to a filing dated Aug. 6, 2026”
Open the source
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
Deal Web
Every firm and person on this deal, and how they connect. Open any name to see their other deals.
Agreement signed · Mangoceuticals agreed to acquire Nuclea (Agreement signed, published 6 Aug 2026).
Announced 6 Aug 2026- Announced
- Published by Mangoceuticals, Inc.
Deal Web as a list
- Mangoceuticals (Buyer) agreed to acquire this deal. Mangoceuticals: 1 deal on Carrywatch.
- Nuclea (Target) target this deal. Nuclea: 1 deal on Carrywatch.
By email · Weekly